<code id='8F48524614'></code><style id='8F48524614'></style>
    • <acronym id='8F48524614'></acronym>
      <center id='8F48524614'><center id='8F48524614'><tfoot id='8F48524614'></tfoot></center><abbr id='8F48524614'><dir id='8F48524614'><tfoot id='8F48524614'></tfoot><noframes id='8F48524614'>

    • <optgroup id='8F48524614'><strike id='8F48524614'><sup id='8F48524614'></sup></strike><code id='8F48524614'></code></optgroup>
        1. <b id='8F48524614'><label id='8F48524614'><select id='8F48524614'><dt id='8F48524614'><span id='8F48524614'></span></dt></select></label></b><u id='8F48524614'></u>
          <i id='8F48524614'><strike id='8F48524614'><tt id='8F48524614'><pre id='8F48524614'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:87638
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          How one patient went off dialysis — and others can too
          How one patient went off dialysis — and others can too

          Melissa“Liddy”LawsonphotographedinSanFrancisco,whereshewashospitalizedfornearlysixmonths.ConstanzaHe

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Menendez indictment could see pharma lose a key ally

          Sen.BobMenendez(D-N.J.)MichaelM.Santiago/GettyImagesWASHINGTON—WithmountingcallsforembattledSen.BobM